New Pfizer/BioNTech vaccine variant shows enhanced protection against COVID-19 hospitalization

Study demonstrates that the BNT162b2 SARS-CoV-2 XBB1.5 variant-modified vaccine significantly reduces the risk of COVID-19-related hospitalizations and ambulatory visits, outperforming previous vaccine versions in the face of evolving virus strains.

Specialised Therapeutics licenses CanariaBio’s cancer therapy

Specialised Therapeutics signed an agreement with CanariaBio for licensing oregovomab. Credit: Specialised Therapeutics. Specialised Therapeutics (ST) has entered an exclusive agreement to license Korea-based CanariaBio’s oregovomab for

October 13, 2023

October births linked to higher flu vaccination and lower diagnosis rates

Children born in October are both more likely to be vaccinated against influenza and least likely to be diagnosed with influenza compared with children born

February 22, 2024

Important discovery could lead to novel treatment for obesity

A team comprised primarily of Texas A&M AgriLife Research scientists has made an important discovery that could lead to a novel treatment for obesity and

January 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.